acute pancreatitis szentkereszty zs. md. ph. d. med. habil. ud mhsc inst. surgery
TRANSCRIPT
Acute pancreatitis
Szentkereszty Zs.
MD. Ph. D. Med. habil.
UD MHSC Inst. Surgery
Atlanta classification I.
Mild acute pancreatitis(< Ranson 3, < APACHE-II 8, no local
and/or systemic complication)
Severe acute pancreatitis(> Ranson 3, > APACHE-II 8, local and/or
systemic complication)
Atlanta classification V. local complications
Pancreas abscess
Atlanta classification VI. local complications
Acute pseudocyst
Atlanta classification VI. systemic complications
• SIRS/MODS/MOF
• ARDS
• Renal failure
• DIC
• sepsis
Modified Atlantai classification
First phase (1th. week)
• SIRS
• MODS/MOF– Mortality spice
• Inflammation, ischemy
– Oedema
– Necrosis
– Liquification
– Fluid collections
Second phase (2th. week)
• Recovery or no
• Mortality spice (infection)
• Local complications
• Local infection’s systemic manifestation (sepsis)
Modified Atlantai classification
First phase (1th. week)
• Characterizated by systemic complications (MODS/MOF)
• Clinical classification
Second phase (2th. week)
• Characterizated by
local complications
• Morphologic classification
Modified Atlantai classification
Criterions of acute pancreatitis
1. Severe acute pain
2. Elevated serum Amylase and/or Lipase levels for minimun three times
3. Typical lesions on CE-CT scan
Minimum 2 criterions needed
Modified Atlantai classification
Scoring
• Puls number > 90/min
• Central temperature > 38 ºC < 36 ºC
• WBC < 4 or > 12 G/L
• Breathong rate > 20/min
• pCO2 < 32 Hgmm
• SIRS
• APACHE-II, Ranson, CRP, etc.
Modified Atlantai classification
Local complications
1. Interstitial oedematous pancreatitis (IEP)• Oedema
• Normal contrast enhance
• Acute peripancreatic fluid collection (endoscopic US, MRI for verify or exclude the necrosis)
Modified Atlantai classification
Local complications
2. Pancreatic necrosis• Localization (pancreatic and/or peripancreatic)
• Sterile or infected
• Staging (Balthazar score: < 30%; 30-50%; > 50%)
• Retrocolic fluid, thickening of the mesenterium
• Necrosis-liquified necrosis (post-necrotic pancreatic fluid collection PNPFC)
• Infection (gas bubbles, FNA)
Sterile necrosis
Infected necrosis
Modified Atlantai classification
Local complications
3. Acute peripancreatic fluid collections (APFC)• No solide content, concomitant of IEP
• No true wall
• Sterile or infected
• Generally sterile
• Spontaneous resolving tendency
Acute peripancreatic fluid collection
Modified Atlantai classification
Local complications
4. Post-necroticus pancreatic/peripancreatic fluid collection (PNPFC)• Solid content in the fluid, concomitant of PN
• Develeopes after 3-6 weeks
• Walled-off pancreatic necrosis (WOPN)
• Sterile or infected- gas bubble, FNA
• Generally sterile
• Spontaneous resolving tendency
Modified Atlantai classification
Local complications
5. Pancreatic pseudocyst• Developes after 4-6 weeks• Developement from APFC• No solide contant• Well definied wall
• Sterile or infected- gas bubble, FNA
• Generally sterile• No spontaneous resolving tendency
Etiology
• Alcohol
• Gallstone disease
• Hyperlipidaemy
• Hypercalcaemy
• Trauma
• Viral infectuions
• Idiopathic
• Ductal obstruction
– Tumour, diseases of the papilla
• Postoperative
• Iatrogenic
– ERCP
Sex & age ratio
0
5
10
15
20
25
No. Of patients
0-20 21-30 31-40 41-50 51-60 61-
years
male
female
all
Complaints
• Pain
• Nausea, vomiting
• Tachycardia
• fever
• Swelling
• Paralytic ileus
• Hypotension, shock
• Renal failure
• Dyspnoe
• Coagulopathy (DIC)
• Cullen sign
• Grey-Turner sign
• Jaundice
• Sepsis
Diagnosis I.
• Case history
• Complaints
• Laboratory– Elevated serum and urine Amylase, serum Lipase
levels
– Trypszin, Trypszinogén α-2, TAP, Foszfolipase,
– WBC, CRP, Htc, Liver function, serum Ca+, ASTRUP levels
– TNFα, IL-6, PCT, Coagulation, stb.
Diagnosis II.
• Native chest and abdominal X-ray
• US
• CE-CT
• MR
• Leukocyta scintigraphy (if needed)
Diagnosis III.
Diagnosis IV.
Diagnosis V.
Diagnosis VI.
Mild acute pancreatitis
Non bacterial origin
Pathologic laesion (oedema)
Local „disease”
Recovery for conservative treatment (generally)
Mild acute pancreatitis
Conservative treatment
• „put the pancreas in rest”
• Gastric tube (suction)
• Ice/cold locally
Conservative treatment
• Intravenous fluids
• PPI
• Pain killers
• spamolithics
• EST
• Cholecystectomy
Severe acute pancreatitis
Non bacterial origin
Pathologic laesion (eg. necrosis)
In origin local than general disease
(SIRS, MODS/MOF )
Septic complications
(abscess)
Severe acute pancreatitis
Patomechanism
• Autodigestive theory– A Trypsonogen-trypsin system activation in the
gland parenchyma– membrane damage of the ductal cells – Damage of the defensive system
• Ductal pressure elevation (in biliary panreatitisben)• The alcohol decreases the sensitivness of the acinal cells for
cholecystokinin, membrane damage of zymogen granulums
A severe acute (necrotisans) pancreatitis
Patomechanism
• Autodigestive theory– Autodigestion, release of free oxygen radics– Tissue damage– Migration of monocytes, macrophags and neutrophyl
granulocyts- cytokine secretion• TNF, IL-1, IL-6, IL-8, INF-ok, PAF, Colonia stimulants, CICAM-1,
– Mediators– Vasoactive agents
A severe acute (necrotisans) pancreatitis
Patomechanism
• Autodigestion– Local effects
• + NO and PAF increase the permeability of the small vessels, causes edema and decreases the microcirculation of the pancreas
• Systemic effects
A severe acute (necrotisans) pancreatitis
Patomechanism
• Microcirculation theory– Local effect
• + NO and PAF increase the permeability of the small vessels, causes edema and decreases the microcirculation of the pancreas
A severe acute (necrotisans) pancreatitis
Patomechanism
• Systemic effects– The vasoactive agents and cytikines causes organ failure (SIRS)
– MODS than MOF• Shock
• Renal failure
• DIC
• ARDS – alveolar microthrombuses
– Lecitinase causes the destruction of surfactan
Treatment I.
Konservative treatmentKonservative treatment
• ICU• Fluid and electrolyte resuscitation• Put the pancreas in rest• Painkillers, spasmolytics, EDA• Treatment of SIRS/MODS/MOF
Konservative treatment
• Fluid and elextrolyte resustitation (4-6000 ml/day)
• Blood gas correction
• Pain killers
• EDA
• Naso-gastric tube
• H2 blocker, PPI
k o n zerv a tív k ezelé s
en y h e
m û té t
szö v õ d m én y(v érzés , p erf o ra tio )
k o n zerv a tív k ezelé s
s teril n ecro s i s
m û té t
n em g y ó g y u l g y ó g y u l
P P D
sep ticu s n ecro s is
A n tib io tik u mN a so -jeu n á lis tá p lá lásP P D -fo ly a d ék g y ü lem
In ten zív o sztá l yC T (n ecro s is )
sú ly o s
A P A C H E -I IR a n so n sco r e
D g .: a cu t p a n crea titi sk lin ik um
la b o rU H
Conservative treatment
• Antibiotic prophylaxisAntibiotic prophylaxis imipenem/cilastatin 3x500 mg
• AB therapy
• Thoracocentesis
• Chest tube drainage
• Treatment of MODS Thrombosis prophylaxis
Treatment
Early enteral jejunal tube feedingEarly enteral jejunal tube feeding
• Scientific basis– Bowel mucosa atrophia– Bacterium translocation– CCK-PZ system– Disadventages of TPN
Naso-jejunal tube feedeing
• Within 48 hour insert the naso-jejunal feeding tube
• Next day start the feeding
• Increase the dosage of nutrients
k o n zerv a tív k ezelé s
en y h e
m û té t
szö v õ d m én y(v érzés , p erf o ra tio )
k o n zerv a tív k ezelé s
s teril n ecro s i s
m û té t
n em g y ó g y u l g y ó g y u l
P P D
sep ticu s n ecro s is
A n tib io tik umN a so -jeu n á lis tá p lá lásP P D -fo ly a d ék g y ü lem
In ten zív o sztá l yC T (n ecro s is )
sú ly o s
A P A C H E -I IR a n so n sco r e
D g .: a cu t p a n crea titi sk lin ik um
la b o rU H
Naso-jejunal tube feedeing
• 25-30 kcal/kg/day (1500-2000 ml nutrien)
• Enteral pump
Treatment
Antibioticum prophylaxisAntibioticum prophylaxis
• Scentific basis:– Adevantage only in severe cases– Spectrum of the bacterial agents in septic
complications– Effective antibiotics– inough penetration and tissue concentration– Imipenem, Fluorokinolons
Treatment
Percutaneous peripancreatic drainagePercutaneous peripancreatic drainage
• Scientific basis:– Developement of interventional radiology– Good effects of other fluid drainages– Later the large fluid collection was an indication
for surgery
Percutaneous peripancreatic drainage
Acute peripancreatic fluid collections
• PPD
35%
• In 20% more than one drain
k o n zerv a tív k ezelé s
en y h e
m û té t
szö v õ d m én y(v érzés , p erf o ra tio )
k o n zerv a tív k ezelé s
s teril n ecro s i s
m û té t
n em g y ó g y u l g y ó g y u l
P P D
sep ticu s n ecro s is
A n tib io tik umN a so -jeu n á lis tá p lá lásP P D -fo ly a d ék g y ü lem
In ten zív o sztá l yC T (n ecro s is )
sú ly o s
A P A C H E -I IR a n so n sco r e
D g .: a cu t p a n crea titi sk lin ik um
la b o rU H
Percutaneous peripancreatic drainage
• Becterium stain and resistency
• Lavage of the drains
Percutaneous peripancreatic drainage
• US observation
• Remove if the drained fluid is les than 20-30 ml/day and it is sterile
Treatment
SurgerySurgery
• Scientific basis:– Early operation has a high rate of mortality,
reoperations and complications– Thre known of the spread of necrosis– The developement of pancreas surgery
Surgery
Indication for surgeryIndication for surgery• Septic necrosis• Failure of PPD • Failure of conservative
treatment of MODS• Surgical complications
(perforation, bleeding, peritonitis)
• IAH/ACS
k o n zerv a tív k ezelé s
en y h e
m û té t
szö v õ d m én y(v érzés , p erf o ra tio )
k o n zerv a tív k ezelé s
s teril n ecro s i s
m û té t
n em g y ó g y u l g y ó g y u l
P P D
sep ticu s n ecro s is
A n tib io tik u mN a so -jeu n á lis tá p lá lásP P D -fo ly a d ék g y ü lem
In ten zív o sztá l yC T (n ecro s is )
sú ly o s
A P A C H E -I IR a n so n sco r e
D g .: a cu t p a n crea titi sk lin ik u m
la b o rU H
Surgary
Early operation 10-15%Acute abdomenLate operation 85-90%Septic necrosis 60%MOF 20%PPD failure PPD failure 30%30%
Daitgnosis of septic necrosisFNA, PPD , PCT
Surgery
TecniqueTecnique
• Curved upper transversal laparotomy
• Blunt necrectomy• Exploration of retrocolic
spaces• Cholecystectomy + cystic
drain • Postoperative closed bursa
omentalis lavage
Surgery
Surgery
Surgery
Surgery
Treatment
The treatment of biliary ANPThe treatment of biliary ANP
• Scientific basis:– The use of ERCP/EST routinly– The effect, timing and results of EST– The timing of cholecystectomy– The decompression of common bile duct
The treatment of biliary pancreatitis
• EST is possible only in 70% of the cases
• Necrectomy, cholecystectomy and cystic duct drain
• Elective cholecystectomy
E lek tívC h o lecy s tecto m i a
k o n zerv a tív k ezelé s
en y h e
M û té tN ecre cto m i a
C h o lecy s tecto m i a
szö v õ d m én y(v érzés , p erf o ra tio )
E lek tívC h o lecy s tecto m i a
k o n zerv a tív k ezelé s
steril n ecro s i s
N ecre cto m i aC h o lecy s tecto m i a
n em g y ó g y u l
E lek tívC h o lecy s tecto m i a
g y ó g y u l
P P D
szep tik u s n ek ró zis
K o ra i E STA n tib io tik um
N a so -jeju n a lis tá p lá lá sP P D -fo ly a d ék g y ü lem
In ten zív o sztá l yC T (n ecro s is )
sú ly o s
A P A C H E -I IR a n so n sco r e
D g .: a cu t b ilia ris p a n crea titisk lin ik um
la b o rU H